Pediatric Medicine News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–10 of 10 articles
Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen in McCune-Albright Syndrome
Laguna Biotherapeutics Receives FDA Clearance for LGNA-100 Pediatric Leukemia Trial
Novartis Coartem Baby Receives WHO Prequalification as First Malaria Treatment for Newborns
BrioHealth Solutions Receives FDA Conditional Approval for Pediatric BrioVAD Heart Device Trial
Novo Nordisk's Oral Semaglutide Shows Promise as First GLP-1 Therapy for Children with Type 2 Diabetes
Dupixent Becomes First Biologic Approved for Chronic Spontaneous Urticaria in Children Ages 2-11
Dupixent Becomes First Biologic Approved for Children Ages 2-11 with Chronic Spontaneous Urticaria
Sanofi's Tzield Approved by FDA for Children as Young as 1 Year to Delay Type 1 Diabetes Progression
FDA Approves Sanofi's Tzield for Children Age 1+ to Delay Type 1 Diabetes Onset
FDA Approves RAPIBLYK (Landiolol) for Pediatric Supraventricular Tachycardia - AOP Health US Expands Critical Care Treatment Options